Last Updated: May 10, 2026

Details for Patent: 5,538,353


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,538,353
Title:Liquid applicator
Abstract:A liquid applicator for applying a desired liquid to a surface includes a closed vial formed of a fracturable material containing the desired liquid, a body having a pocket with an open side and a shape adapted to receive the vial, and a porous element sealed to the body and closing off the open side of the pocket so that liquid flows through the element when the vial is fractured. The body has a flange protruding from the pocket along the open side thereof and a wing-like gripping member projects from the flange. The gripping member is spaced from the pocket and supported for pivoting movement relative to the pocket by the flange. The body also has structure for fracturing the vial, the structure being interposed between the pocket and gripping member. Upon pivoting of the gripping member, the structure flexes the pocket inwardly to exert a fracturing force against the vial when the member is pivoted towards the pocket.
Inventor(s):Lesley M. DeHavilland
Assignee: FIRST SOURCE FINANCIAL Inc , CareFusion 2200 Inc
Application Number:US08/519,575
Patent Claim Types:
see list of patent claims
Delivery;
Patent landscape, scope, and claims:

United States Patent 5,538,353: Scope, Claims, and US Patent Landscape for Fracturable Vial Liquid Applicators

United States Patent US 5,538,353 is directed to a liquid applicator that uses an elongated, fracturable closed vial and an actuatable body to fracture the vial and meter liquid through a porous element. The enforceable claim core is the mechanical fracture architecture: wing-like gripping members that pivot relative to a flange to drive tabs that flex a pocket inwardly and fracture the vial, combined with a porous closure that controls liquid release only after fracture.


What does US 5,538,353 claim cover in practice?

US 5,538,353’s independent claim set (claims 1 and 8) covers an applicator with these technical pillars:

  1. A fracturable, closed vial

    • Elongated closed vial
    • Made of fracturable material
    • Contains a liquid to be applied
    • Has a central longitudinal axis
  2. A body with an elongated pocket and an open side

    • The body includes an elongated pocket with an open side
    • The pocket axis is generally collinear with the vial axis when received
    • The body includes a flange protruding along the open side
    • The open side is closed off by a porous element secured to the body
  3. Wing-like gripping members that pivot to fracture

    • A pair of elongated, wing-like gripping members (claim 1) or a single wing-like member (claim 8)
    • Members project from the flange
    • Members are spaced from the pocket
    • Members are supported for pivoting movement relative to the pocket by the flange
    • A fracture-actuation structure is placed between the pocket and gripping members
    • When the members move toward one another (claim 1) or toward the pocket (claim 8), the fracture structure flexes the pocket inwardly to exert a fracture force on the vial
  4. Tabs that localize pocket flexing and fracture force

    • Claim 1 and its dependents define retaining and breaking tabs that position the inward flexing at specific axial locations:
      • Retaining tab moves the pocket inwardly between an axial plane and the flange, and forces the vial away from the open side (claims 3, 4, 6, 7, 14, 16, 18, 20)
      • Breaking tabs move the pocket inwardly generally at the axis of the pocket or along the pocket at an axial plane location (claims 3, 4, 6, 7, 15, 16, 19, 20)
    • Alternative tab counts and layouts appear in claims 5 and 9
  5. Porous element controlling liquid flow post-fracture

    • A porous element is secured to the body and closes off the pocket open side
    • Liquid flows through the porous element when the vial is fractured
    • This ties function to structure: the porous element is not just present, it is the delivery pathway after fracture.

Claim-by-claim scope decomposition

H2: Independent claims 1 and 8 define two closely related framing embodiments

H3: Claim 1 (two gripping members, bidirectional pivoting)

Claim 1 requires:

  • Elongated closed vial of fracturable material, with central axis
  • Elongated pocket with open side and pocket axis
  • Pocket axis is collinear with vial axis when received
  • Pocket has an axial plane including the pocket axis, parallel to the open side
  • Flange protruding from pocket along open side
  • Pair of elongated wing-like gripping members
    • Project from flange
    • Supported for pivoting movement relative to pocket
    • Spaced from pocket
  • Fracturing structure interposed between pocket and gripping members
    • Flexes pocket inwardly to exert fracturing force when gripping members pivot toward one another
  • Porous element closing the open side so liquid flows when vial fractured

Claims 2, 3, 5, 6, 7 and 8-20 variations layer tab geometry and gripping texture.

H3: Claim 8 (single gripping member, “fracturing area less than gripping area”)

Claim 8 shifts emphasis to:

  • Closed vial and pocket/pore architecture remain
  • Includes a wing-like gripping member with a gripping area where squeezing force is applied
  • The fracture structure has a fracturing area that:
    • Flexes the pocket inwardly
    • Transfers the squeezing force to the vial when the member is pivoted
    • Has a strict size relationship: fracturing area is less than gripping area
  • Porous element remains the release pathway post-fracture

Claims 9-20 then impose tab architectures and pocket axis/axial plane relationships.

Landscape impact: Claim 8 introduces an additional design-specific limitation (fracturing area smaller than gripping area), which can narrow non-infringing equivalents if competitors distribute force differently.


H2: What structural limitations are most likely to determine infringement?

The highest-risk limitations are the ones that define mechanical co-location and force transfer.

H3: Pocket-to-gripping articulation

US 5,538,353 requires gripping members to be:

  • Spaced from the pocket
  • Pivoting relative to the pocket supported by the flange
  • Actuation occurs via pivoting that drives tabs/fracturing structure to flex the pocket

If an accused device fractures a vial via:

  • sliding action,
  • axial compression without pivoted wing members,
  • internal hammering without a pocket flexing mechanism, it is outside the literal scaffold.

H3: Retaining tab vs breaking tabs placement

The tab architecture is an enforceable spatial control scheme:

  • Retaining tab location: pocket inward flex at a location between the axial plane and flange, forcing vial away from open side
  • Breaking tab location: inward flex at or aligned with the axial plane/axis, enabling fracture

This is repeatedly claimed across independent/dependent claim sets:

  • Claim 3/4 and Claim 14/15/16
  • Claim 5/6 and Claim 17/18/19
  • Claim 7 and Claim 20 with oblique tab geometry

This makes “where the pocket bends” a key design variable.

H3: Porous element as the closed-open side delivery interface

The claim requires a porous element securing and closing off the open side, with flow through the element after fracture. A design that uses:

  • a valve,
  • a wicking channel that is not porous element-secured closure,
  • a direct spout after fracture, may fail on the “porous element closing off open side” requirement.

Dependent claim variations: what they add and what they narrow

H2: Grip texture and handling features (Claim 2, Claim 12)

  • Each gripping member includes:
    • a rib spaced from the flange along the length
    • a textured surface between rib and flange
  • Purpose is handling but it becomes a claim limitation.

Enforcement implication: textured ribs are narrow features. Devices without ribs/textures can still infringe the core (claims 1 or 8), depending on claim chart mapping.

H2: Tab counts and configurations (Claims 3, 5, 9, 11, 13, 17)

Tab architectures include:

  • Single retaining tab + single breaking tab (claim 3 and claim 13 for the conceptual pair)
  • Single retaining tab + pair of spaced-apart breaking tabs (claims 5 and 17)
  • Plural tabs spaced along the pocket (claim 9)
  • At least one tab per gripping member (claim 11), with at least one tab adjacent each gripping member
  • Claims include explicit spacing:
    • breaking tabs spaced axially from retaining tab (claim 5, claim 17)

Narrowing effect: tab count, axial spacing, and adjacency to specific gripping members can differentiate non-infringing designs.

H2: Tab activation geometry: oblique tabs and engagement surface definitions (Claims 4, 7, 16, 20)

Key geometry limits include:

  • Engagement surfaces:
    • Retaining tab engagement surface intersects pocket between axial plane and flange (claim 4, claim 16)
    • Breaking tab engagement surface intersects pocket aligned with axial plane (claim 4, claim 16)
  • Oblique tab extension:
    • Retaining tab extends obliquely from one gripping member to pocket location between axial plane and flange, and extends along pocket to flange (claim 7)
    • Breaking tabs extend obliquely from the other gripping member generally to axial plane and extend along pocket to flange (claim 7, claim 20)

Enforcement implication: the “intersection location” and “obliquely extending to flange” language is specific; competitors can reduce literal overlap by changing tab orientation or eliminating the flange-to-tab continuous extension.


H2: Concrete claim limitation matrix (structure-to-feature mapping)

Claim element Claim 1 Claim 8 Key dependent additions
Fracturable closed vial Yes Yes Vial elongated (claims 10, 11)
Elongated pocket with open side Yes Yes Axial plane defined (claims 1, 10)
Pocket axis collinear with vial axis Yes Yes Explicit collinearity (claim 10)
Flange along open side Yes Yes Axial plane parallel to open side (claim 10)
Wing-like gripping member(s) pivot via flange Pair in claim 1 Single in claim 8 Ribs/textures on members (claims 2, 12)
Fracturing structure between pocket and gripping members Yes Yes Fracturing area sizing (claim 8)
Pocket flexing inward to fracture vial Yes Yes Tabs drive localized flex (claims 3-7, 11, 13, 17-20)
Porous element closing pocket open side Yes Yes Liquid flows after fracture (claims 1, 8)
Retaining tab forces vial away from open side Yes (via dependents) Yes (via dependents) Placement between axial plane and flange (claims 3, 14, 18)
Breaking tab(s) flex at axial plane Yes (via dependents) Yes (via dependents) Breaking at axis/axial plane (claims 3, 15, 19)

Patent landscape: what surrounds US 5,538,353 in US prosecution and design space

H2: How to interpret “landscape” for this specific patent type

US 5,538,353 is a mechanical device patent for dispensing liquid from a fracturable vial through a porous element. The likely adjacent prior art clusters in the US system are:

  • Fracturable ampoule/vial dispensers (manual fracture to release contents)
  • Actuated piercing/pressing delivery systems (fracture or pierce, then flow through some outlet)
  • Topical liquid applicators that use foams, sponges, porous pads, or wicking surfaces
  • Child-resistant or controlled-release dispensing mechanisms using non-threaded break structures and controlled release after actuation
  • Applicator bodies with pivoting grips that apply localized force via flexing members or tabs

Business relevance: for freedom-to-operate planning, the landscape risk is less about “topical porous applicators” alone and more about the intersection of:

  • fracturable elongated vials plus
  • localized mechanical fracture via pivoted gripping members plus
  • porous element closure at the open side.

H2: Practical risk assessment against plausible competing designs (non-infringement levers)

These are the design levers that directly attack literal claim coverage based on the claim text:

  1. Replace pivoting wing members with a different actuation

    • If a device fractures without pivoting members supported by a flange, it avoids the core mechanical articulation.
  2. Change pocket flexing locus

    • If the inward pocket flexing does not occur at the defined axial relationships (between axial plane and flange for retaining tab function; at the axial plane/axis for breaking tab function), claim 3/4/14-20 alignment fails.
  3. Remove the porous element that closes the open side

    • If the device uses a different release outlet structure, it risks failure of the “porous element secured to the body and closing off the open side” limitation.
  4. Eliminate the defined force localization relationship

    • For claim 8, enforceability depends on the fracturing area being less than the gripping area. Designing to distribute force across equal or larger contact zones can reduce literal overlap.

H2: Expiry and enforcement posture in the US

US 5,538,353 is a 1996 grant. For US device claims, enforceability is driven by:

  • filing/prosecution history and maintenance fees,
  • and term rules applicable to the application.

As a business planning matter, the core claim coverage described above still informs:

  • patentability comparisons for new mechanical designs,
  • and licensing landscapes where continuation or improvement patents exist around the same dispensing mechanism.

(Any assessment of current enforceability status requires a procedural docket/USPTO status check against the specific patent record.)


Key Takeaways

  • US 5,538,353 protects a fracturable elongated vial applicator where pivoting wing-like gripping members drive tab-controlled pocket flexing to fracture the vial and release liquid through a porous element closure.
  • The enforceability focus is on mechanical force transfer geometry: retaining tabs flex the pocket between the axial plane and flange and breaking tabs act at or aligned with the axial plane/axis.
  • Claim 8 adds a distinct narrowing constraint: fracturing area < gripping area, which can be a design differentiator.
  • Texture ribs and tab counts/obliqueness are narrowing features; the base architecture is the pocket-plus-flange-plus-pivot-plus-porous release after fracture.

FAQs

H2: What is the single most important limitation in US 5,538,353 for mapping competitors?

The requirement that the vial is fractured by pocket flexing driven by pivoting wing-like gripping members through a fracturing/tabs structure, while a porous element closes off the pocket open side so liquid flows through it after fracture.

H2: Do the claims require both retaining and breaking tabs?

Not in claim 1’s base language, but retaining/breaking tab structures are explicitly claimed in multiple dependents (claims 3-7 for claim 1 and claims 14-20 for claim 8 chain). Devices matching the base structure can still be evaluated against the independent claims even if they diverge in tab details.

H2: How does claim 8 differ from claim 1 in a way that affects design-around?

Claim 8 requires the fracturing area on the fracturing structure be less than the gripping area. This is an explicit sizing relationship not stated in claim 1.

H2: Are textured grips required to infringe?

Textured rib features are in dependent claims (claims 2 and 12). They are not needed for literal coverage of independent claim 1 or 8, though they matter for dependent claim infringement.

H2: What design changes most directly reduce literal overlap?

Switch actuation away from pivoting wing members supported by a flange, change the axial location where the pocket flexing occurs relative to the axial plane/flange, and replace the porous element closure mechanism for post-fracture liquid release.


References

[1] U.S. Patent No. 5,538,353. United States Patent and Trademark Office (USPTO).

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 5,538,353

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.